Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385442092> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4385442092 abstract "Abstract: Neurodegenerative disorders (NDs) are a group of progressive, chronic, and disabling disorders that are highly prevalent and the incidence is on a constant rise globally. Alzheimer’s disease (AD), one of the most common neurodegenerative disorders is hallmarked by cognitive impairment, amyloid-β (Aβ) deposition, hyperphosphorylation of tau protein, cholinergic dysfunction, mitochondrial toxicity, and neurodegeneration. Available therapeutic agents only provide symptomatic relief and their use are limited due to serious side effects. Recent research has recognized flavonoids as potential multi-target biomolecules that can reduce the pathogenesis of AD. Naringin, a natural citrus flavonoid has been traditionally used to treat various NDs including AD, and has gained special attention because exhibits a neuroprotective effect by affecting numerous signaling pathways with minimum adverse effects. Naringin reduces deposition of Aβ, hyperphosphorylation of tau protein, cholinergic dysfunction, oxidative stress burden, mitochondrial toxicity, the activity of glutamate receptors, and apoptosis of the neuronal cells. Additionally, it reduces the expression of phosphorylated-P38/P38 and the NF-κB signaling pathway, showing that a wide range of molecular targets is involved in naringin's neuroprotective action. The present study describes the possible pharmacological targets, signaling pathways, and molecular mechanisms of naringin involved in neuroprotection against AD-like pathology. Based on the above pre-clinical reports it can be concluded that naringin could be an alternative therapeutic agent for the management of AD-like manifestation. Thus, there is a strong recommendation to perform more preclinical and clinical studies to develop naringin as a novel molecule that could be a multi-target drug to counteract AD." @default.
- W4385442092 created "2023-08-02" @default.
- W4385442092 creator A5003109636 @default.
- W4385442092 creator A5050581221 @default.
- W4385442092 date "2023-08-01" @default.
- W4385442092 modified "2023-09-27" @default.
- W4385442092 title "Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer’s Disease-like Pathology: A Comprehensive Review" @default.
- W4385442092 doi "https://doi.org/10.2174/1389201024666230801095526" @default.
- W4385442092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37526460" @default.
- W4385442092 hasPublicationYear "2023" @default.
- W4385442092 type Work @default.
- W4385442092 citedByCount "0" @default.
- W4385442092 crossrefType "journal-article" @default.
- W4385442092 hasAuthorship W4385442092A5003109636 @default.
- W4385442092 hasAuthorship W4385442092A5050581221 @default.
- W4385442092 hasConcept C126322002 @default.
- W4385442092 hasConcept C169760540 @default.
- W4385442092 hasConcept C184235292 @default.
- W4385442092 hasConcept C25498285 @default.
- W4385442092 hasConcept C2776925932 @default.
- W4385442092 hasConcept C2777335409 @default.
- W4385442092 hasConcept C2778198054 @default.
- W4385442092 hasConcept C2779134260 @default.
- W4385442092 hasConcept C502032728 @default.
- W4385442092 hasConcept C54355233 @default.
- W4385442092 hasConcept C60644358 @default.
- W4385442092 hasConcept C71924100 @default.
- W4385442092 hasConcept C86803240 @default.
- W4385442092 hasConcept C95444343 @default.
- W4385442092 hasConcept C98274493 @default.
- W4385442092 hasConceptScore W4385442092C126322002 @default.
- W4385442092 hasConceptScore W4385442092C169760540 @default.
- W4385442092 hasConceptScore W4385442092C184235292 @default.
- W4385442092 hasConceptScore W4385442092C25498285 @default.
- W4385442092 hasConceptScore W4385442092C2776925932 @default.
- W4385442092 hasConceptScore W4385442092C2777335409 @default.
- W4385442092 hasConceptScore W4385442092C2778198054 @default.
- W4385442092 hasConceptScore W4385442092C2779134260 @default.
- W4385442092 hasConceptScore W4385442092C502032728 @default.
- W4385442092 hasConceptScore W4385442092C54355233 @default.
- W4385442092 hasConceptScore W4385442092C60644358 @default.
- W4385442092 hasConceptScore W4385442092C71924100 @default.
- W4385442092 hasConceptScore W4385442092C86803240 @default.
- W4385442092 hasConceptScore W4385442092C95444343 @default.
- W4385442092 hasConceptScore W4385442092C98274493 @default.
- W4385442092 hasLocation W43854420921 @default.
- W4385442092 hasLocation W43854420922 @default.
- W4385442092 hasOpenAccess W4385442092 @default.
- W4385442092 hasPrimaryLocation W43854420921 @default.
- W4385442092 hasRelatedWork W2003411707 @default.
- W4385442092 hasRelatedWork W2035480975 @default.
- W4385442092 hasRelatedWork W2037945568 @default.
- W4385442092 hasRelatedWork W2050697792 @default.
- W4385442092 hasRelatedWork W2065432348 @default.
- W4385442092 hasRelatedWork W2090640734 @default.
- W4385442092 hasRelatedWork W2095181308 @default.
- W4385442092 hasRelatedWork W2957799047 @default.
- W4385442092 hasRelatedWork W2965035470 @default.
- W4385442092 hasRelatedWork W291561 @default.
- W4385442092 hasVolume "24" @default.
- W4385442092 isParatext "false" @default.
- W4385442092 isRetracted "false" @default.
- W4385442092 workType "article" @default.